AVITA MEDICAL, INC.

RCEL

CIK 0001762303 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$18M
↓-4.3% -$791Kvs FY2024 (Q4)
Operating Income
$8M
↓-27.3% -$3Mvs FY2024 (Q4)
Net Income
$7M
↓-30.4% -$3Mvs FY2024 (Q4)
Gross Profit
$14M
↓-11.3% -$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
45/100
  • Profitability
    0ROIC -223.3% (10% = solid, 20%+ = moat)
  • Liquidity
    3Current Ratio 0.57 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    66Asset Turnover 1.05x (1.0+ = capital-efficient)
  • Growth
    2Revenue YoY -4.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -53.6% · trend +50.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$2M
investment in PP&E
Stock-based comp (TTM)
$10M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$56M
everything owned
Total liabilities
$73M
everything owed
Stockholders' equity
$-17M
shareholder claim
Net debt
$-10M
Net cash position ($10M)

Recent performance · 32 quarters

Revenue↓-4.3% -$791K
$18M
Net Income↑+18.6% +$3M
$-13M
Free Cash Flow↑+75.2% +$3M
$-934K
Operating Margin↑+17.0pts
-53.6%

Drill down